ENDRA Life Sciences (NDRA) FCF Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) has reported FCF Margin for 3 consecutive years, with 39713.15% the latest figure, recorded in Q1 2018.

• On a quarterly basis, FCF Margin changed N/A year-over-year to 39713.15% in Q1 2018; TTM through Dec 2018 was 126376.43%, a 12543767.0% decrease from a year earlier, with the FY2018 full-year figure at 126376.43%, down 12543543.0% from the prior year.
• FCF Margin was 39713.15% for Q1 2018 at ENDRA Life Sciences, down from 20081.52% in the prior quarter.
• Over five years, FCF Margin peaked at 105.93% in Q4 2016 and troughed at 39713.15% in Q1 2018.
• A 3-year average of 12413.71% and a median of 1977.51% in 2017 frame the typical range for FCF Margin.
• The widest YoY moves for FCF Margin: up 1997559 bps in 2017, down 1997559 bps in 2017.
• Over 3 years, FCF Margin stood at 105.93% in 2016, then tumbled by 18857 bps to 20081.52% in 2017, then slumped by 98 bps to 39713.15% in 2018.
• The last three FCF Margin figures came in at 39713.15% (Q1 2018), 20081.52% (Q4 2017), and 190.46% (Q3 2017), per Business Quant data.